GlassScriptPhysician profile
David J Moreland
NPI 1104831924
$62,647.41
in general payments reported to CMS, 2019-2025
14 companies · $7,969 in 2025
The $7,969 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $7,159 · 2021: $11K · 2022: $7,308 · 2023: $6,000 · 2024: $3,198 · 2025: $7,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $16,321.16 |
| Food and Beverage | $845.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $31,642.08 | 2021-2025 | Nexplanon, Vtama |
| Merck Sharp & Dohme LLC | $29,615.57 | 2019-2021 | |
| Conmed Corporation | $800.00 | 2019 | |
| Hologic Sales and Service, LLC | $122.21 | 2019 | |
| Astellas Pharma US INC | $122.19 | 2019-2023 | Veozah |
| Abbvie INC. | $116.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.49 | 2019-2020 | |
| Smith+Nephew, INC. | $46.19 | 2019 | |
| Coopersurgical, INC. | $29.46 | 2019 | |
| Roche Diagnostics Corporation | $22.56 | 2019 | |
| Genentech USA, INC. | $20.30 | 2020 | |
| Covidien LP | $13.51 | 2019 | |
| Convatec INC. | $12.85 | 2019 | |
| Ethicon US, LLC | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Moreland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.